SEC Form 4 · accession 0001127602-19-008340
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 25, 2019
Accepted (ET)
Feb 26, 2019 · 3:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2019 | S | 100 | $145.275 | D | 295,622 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.28 | D | 295,522 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.285 | D | 295,422 | D | |
| Common Stock | Feb 25, 2019 | S | 500 | $145.29 | D | 294,922 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $145.31 | D | 294,522 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.315 | D | 294,422 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.32 | D | 294,222 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.33 | D | 294,122 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.34 | D | 293,922 | D | |
| Common Stock | Feb 25, 2019 | S | 147 | $145.345 | D | 293,775 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.35 | D | 293,675 | D | |
| Common Stock | Feb 25, 2019 | S | 352 | $145.36 | D | 293,323 | D | |
| Common Stock | Feb 25, 2019 | S | 203 | $145.37 | D | 293,120 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $145.38 | D | 292,720 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.39 | D | 292,520 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.42 | D | 292,420 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $145.46 | D | 292,020 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.48 | D | 291,920 | D | |
| Common Stock | Feb 25, 2019 | S | 601 | $145.52 | D | 291,319 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.53 | D | 291,119 | D | |
| Common Stock | Feb 25, 2019 | S | 99 | $145.54 | D | 291,020 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.57 | D | 290,820 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.575 | D | 290,720 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.